REG - Societe Generale SA Takeda Pharma.Co.Ltd - Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD
RNS Number : 3148HSociete Generale SA14 November 2018FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Full name of discloser:
Société Générale S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:
Use a separate form for each offeror/offeree
Takeda Pharmaceutical CO LTD
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:
For an opening position disclosure, state the latest practicable date prior to the disclosure
13/11/2018
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?
If it is a cash offer or possible cash offer, state "N/A"
YES: Shire PLC
2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)
Class of relevant security:
Ordinary
Interests
Short positions
Number
%
Number
%
(1) Relevant securities owned and/or controlled:
1,990,671
0.25
7,726,659
0.99
(2) Cash-settled derivatives:
6,889,533
0.88
0
0.00
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:
121,500
0.02
125,000
0.02
TOTAL:
9,001,704
1.15
7,851,659
1.00
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE
Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.
The currency of all prices and other monetary amounts should be stated.
(a) Purchases and sales
Class of relevant security
Purchase/sale
Number of securities
Price per unit
JPY
Ordinary
Purchase
100
4524
Ordinary
Purchase
1,400
4524
Ordinary
Purchase
600
4491
Ordinary
Purchase
1,900
4527
Ordinary
Purchase
2,500
4516
Ordinary
Purchase
2,500
4514
Ordinary
Purchase
400
4511
Ordinary
Purchase
1,500
4531
Ordinary
Purchase
100
4533
Ordinary
Purchase
200
4544
Ordinary
Purchase
1,500
4511
Ordinary
Purchase
1,800
4515
Ordinary
Purchase
300
4509
Ordinary
Purchase
1,400
4515
Ordinary
Purchase
400
4515
Ordinary
Purchase
100
4510
Ordinary
Purchase
1,400
4507
Ordinary
Purchase
2,500
4516
Ordinary
Purchase
200
4509
Ordinary
Purchase
600
4508
Ordinary
Purchase
300
4509
Ordinary
Purchase
1,400
4510
Ordinary
Purchase
700
4513
Ordinary
Purchase
1,600
4513
Ordinary
Purchase
100
4514
Ordinary
Purchase
2,000
4515
Ordinary
Purchase
1,800
4515
Ordinary
Purchase
400
4526
Ordinary
Purchase
300
4509
Ordinary
Purchase
1,900
4511
Ordinary
Purchase
100
4533.9
Ordinary
Purchase
2,600
4520
Ordinary
Purchase
600
4520
Ordinary
Purchase
300
4535
Ordinary
Purchase
300
4529
Ordinary
Purchase
300
4537
Ordinary
Purchase
300
4521
Ordinary
Purchase
300
4512
Ordinary
Purchase
700
4510.5
Ordinary
Purchase
700
4511.5
Ordinary
Purchase
700
4512
Ordinary
Purchase
1,500
4514.5
Ordinary
Purchase
700
4516
Ordinary
Purchase
1,600
4513.5
Ordinary
Purchase
1,600
4513.5
Ordinary
Purchase
1,000
4513.5
Ordinary
Purchase
100
4509
Ordinary
Purchase
700
4511
Ordinary
Purchase
100
4509.5
Ordinary
Purchase
100
4534.5
Ordinary
Purchase
100
4533.5
Ordinary
Purchase
100
4533.5
Ordinary
Purchase
100
4496.5
Ordinary
Purchase
100
4543.5
Ordinary
Purchase
500
4517
Ordinary
Purchase
100
4533.5
Ordinary
Purchase
1,800
4520
Ordinary
Purchase
100
4539
Ordinary
Purchase
1,100
4514
Ordinary
Purchase
1,000
4534
Ordinary
Purchase
1,100
4518
Ordinary
Purchase
400
4489
Ordinary
Purchase
200
4539
Ordinary
Purchase
1,200
4535
Ordinary
Purchase
1,100
4496
Ordinary
Purchase
1,100
4514
Ordinary
Purchase
1,000
4534
Ordinary
Purchase
500
4518
Ordinary
Purchase
300
4519
Ordinary
Purchase
1,000
4534
Ordinary
Purchase
1,100
4512
Ordinary
Purchase
300
4535
Ordinary
Purchase
1,100
4512
Ordinary
Purchase
1,000
4538
Ordinary
Purchase
500
4514
Ordinary
Purchase
1,000
4531
Ordinary
Purchase
500
4512
Ordinary
Purchase
1,100
4513
Ordinary
Purchase
1,100
4516
Ordinary
Purchase
1,100
4506
Ordinary
Purchase
1,100
4503
Ordinary
Purchase
900
4503
Ordinary
Purchase
500
4505
Ordinary
Purchase
2,200
4508
Ordinary
Purchase
600
4505
Ordinary
Purchase
400
4535
Ordinary
Purchase
1,100
4507
Ordinary
Purchase
200
4519
Ordinary
Purchase
1,100
4521
Ordinary
Purchase
1,000
4512
Ordinary
Purchase
300
4509
Ordinary
Purchase
100
4512
Ordinary
Purchase
1,100
4510
Ordinary
Purchase
100
4512
Ordinary
Purchase
1,000
4509
Ordinary
Purchase
800
4508
Ordinary
Purchase
1,100
4526
Ordinary
Purchase
300
4500
Ordinary
Purchase
500
4526
Ordinary
Purchase
1,100
4512
Ordinary
Purchase
100
4506
Ordinary
Purchase
300
4526
Ordinary
Purchase
500
4506
Ordinary
Purchase
700
4533
Ordinary
Purchase
400
4541
Ordinary
Purchase
700
4542
Ordinary
Purchase
1,100
4514
Ordinary
Purchase
1,100
4514
Ordinary
Purchase
200
4508
Ordinary
Purchase
1,100
4527
Ordinary
Purchase
700
4524
Ordinary
Purchase
1,100
4506
Ordinary
Purchase
1,100
4506
Ordinary
Purchase
500
4525
Ordinary
Purchase
1,100
4508
Ordinary
Purchase
300
4537
Ordinary
Purchase
1,100
4515
Ordinary
Purchase
1,100
4528
Ordinary
Purchase
500
4526
Ordinary
Purchase
500
4518
Ordinary
Purchase
1,100
4502
Ordinary
Purchase
700
4495
Ordinary
Purchase
1,100
4482
Ordinary
Purchase
900
4483
Ordinary
Purchase
1,000
4536
Ordinary
Purchase
900
4534
Ordinary
Purchase
900
4498
Ordinary
Purchase
700
4504
Ordinary
Purchase
700
4506
Ordinary
Purchase
1,100
4526
Ordinary
Purchase
500
4504
Ordinary
Purchase
1,100
4507
Ordinary
Purchase
400
4492
Ordinary
Purchase
700
4509
Ordinary
Purchase
1,200
4512
Ordinary
Purchase
1,000
4540
Ordinary
Purchase
100
4494
Ordinary
Purchase
800
4502
Ordinary
Purchase
900
4502
Class of relevant security
Purchase/sale
Number of securities
Price per unit
USD
ADS
Purchase
138,435
19.83
ADS
Purchase
25,170
19.8828
Class of relevant security
Purchase/sale
Number of securities
Price per unit
JPY
Ordinary
Sale
200
4527
Ordinary
Sale
200
4507
Ordinary
Sale
200
4536
Ordinary
Sale
200
4514
Ordinary
Sale
200
4488
Ordinary
Sale
200
4507
Ordinary
Sale
200
4529
Ordinary
Sale
200
4537
Ordinary
Sale
200
4515
Ordinary
Sale
200
4512
Ordinary
Sale
200
4522
Ordinary
Sale
200
4525
Ordinary
Sale
100
4500
Ordinary
Sale
100
4500
Ordinary
Sale
200
4512
Ordinary
Sale
200
4517
Ordinary
Sale
100
4527
Ordinary
Sale
200
4513
Ordinary
Sale
200
4519
Ordinary
Sale
200
4517
Ordinary
Sale
200
4516
Ordinary
Sale
200
4511
Ordinary
Sale
200
4505
Ordinary
Sale
200
4539
Ordinary
Sale
200
4518
Ordinary
Sale
200
4540
Ordinary
Sale
200
4522
Ordinary
Sale
200
4541
Ordinary
Sale
200
4513
Ordinary
Sale
200
4544
Ordinary
Sale
200
4490
Ordinary
Sale
200
4511
Ordinary
Sale
200
4516
Ordinary
Sale
200
4527
Ordinary
Sale
200
4533
Ordinary
Sale
100
4520.1
Ordinary
Sale
1,200
4507
Ordinary
Sale
300
4489
Ordinary
Sale
400
4525
Ordinary
Sale
2,400
4538
Ordinary
Sale
700
4508
Ordinary
Sale
200
4487
Ordinary
Sale
100
4487
Ordinary
Sale
100
4488
Ordinary
Sale
1,400
4490
Ordinary
Sale
100
4521
Ordinary
Sale
500
4518
Ordinary
Sale
300
4487
Ordinary
Sale
1,400
4535
Ordinary
Sale
800
4496
Ordinary
Sale
1,200
4507
Ordinary
Sale
400
4509
Ordinary
Sale
600
4502
Ordinary
Sale
1,800
4509
Ordinary
Sale
1,600
4503
Ordinary
Sale
600
4508
Ordinary
Sale
500
4507
Ordinary
Sale
1,200
4508
Ordinary
Sale
1,100
4514
Ordinary
Sale
900
4512
Ordinary
Sale
100
4516
Ordinary
Sale
900
4511
Ordinary
Sale
1,500
4511
Ordinary
Sale
2,400
4522
Ordinary
Sale
2,500
4512
Ordinary
Sale
1,800
4508
Ordinary
Sale
2,500
4518
Ordinary
Sale
2,500
4518
Ordinary
Sale
1,000
4505
Ordinary
Sale
2,000
4516
Ordinary
Sale
400
4509
Ordinary
Sale
2,100
4529
Ordinary
Sale
2,400
4534
Ordinary
Sale
100
4504
Ordinary
Sale
3,600
4498
Ordinary
Sale
1,600
4512
Ordinary
Sale
300
4512
Ordinary
Sale
100
4501
Ordinary
Sale
2,500
4516
Ordinary
Sale
800
4531
Ordinary
Sale
1,700
4507
Ordinary
Sale
200
4511
Ordinary
Sale
400
4508
Ordinary
Sale
1,500
4510
Ordinary
Sale
100
4520
Ordinary
Sale
400
4516
Ordinary
Sale
100
4528
Ordinary
Sale
400
4510
Ordinary
Sale
100
4508
Ordinary
Sale
1,500
4528
Ordinary
Sale
100
4507
Ordinary
Sale
200
4512
Ordinary
Sale
100
4508
Ordinary
Sale
1,100
4528
Ordinary
Sale
600
4536
Ordinary
Sale
600
4512
Ordinary
Sale
300
4507
Ordinary
Sale
500
4504
Ordinary
Sale
1,400
4509
Ordinary
Sale
1,500
4511
Ordinary
Sale
1,500
4510
Ordinary
Sale
400
4533
Ordinary
Sale
300
4513
Ordinary
Sale
200
4505
Ordinary
Sale
1,500
4503
Ordinary
Sale
600
4504
Ordinary
Sale
1,700
4516
Ordinary
Sale
1,300
4531
Ordinary
Sale
2,400
4532
Ordinary
Sale
1,200
4505
Ordinary
Sale
400
4513
Ordinary
Sale
1,900
4512
Ordinary
Sale
1,900
4512
Ordinary
Sale
500
4513
Ordinary
Sale
1,400
4516
Ordinary
Sale
1,400
4530
Ordinary
Sale
1,100
4531
Ordinary
Sale
600
4514
Ordinary
Sale
1,600
4512
Ordinary
Sale
400
4506
Ordinary
Sale
1,200
4519
Ordinary
Sale
100
4520
Ordinary
Sale
1,600
4530
Ordinary
Sale
1,000
4543
Ordinary
Sale
400
4525
Ordinary
Sale
300
4509
Ordinary
Sale
2,100
4529
Ordinary
Sale
400
4508
Ordinary
Sale
500
4526
Ordinary
Sale
1,200
4525
Ordinary
Sale
700
4503
Ordinary
Sale
4,600
4536
Ordinary
Sale
1,000
4511
Ordinary
Sale
1,500
4510
Ordinary
Sale
1,400
4501
Ordinary
Sale
1,600
4511
Ordinary
Sale
1,400
4497
Ordinary
Sale
700
4510
Ordinary
Sale
1,300
4508
Ordinary
Sale
800
4487
Ordinary
Sale
1,400
4488
Ordinary
Sale
1,900
4510
Ordinary
Sale
1,100
4493
Ordinary
Sale
2,400
4492
Ordinary
Sale
900
4512
Ordinary
Sale
500
4505
Ordinary
Sale
1,600
4511
Ordinary
Sale
2,400
4520
Ordinary
Sale
100
4506
Ordinary
Sale
1,700
4518
Ordinary
Sale
100
4509
Ordinary
Sale
900
4508
Ordinary
Sale
800
4506
Ordinary
Sale
1,400
4505
Ordinary
Sale
700
4509
Ordinary
Sale
1,500
4531
Ordinary
Sale
1,600
4511
Ordinary
Sale
300
4491
Ordinary
Sale
400
4495
Ordinary
Sale
500
4496
Ordinary
Sale
200
4495
Ordinary
Sale
3,500
4513
Ordinary
Sale
100
4508
Ordinary
Sale
100
4523
Ordinary
Sale
400
4512
Ordinary
Sale
1,100
4509.5
Ordinary
Sale
300
4510.5
Ordinary
Sale
1,400
4520
Ordinary
Sale
3,700
4520
Ordinary
Sale
1,100
4512
Ordinary
Sale
700
4504
Ordinary
Sale
100
4506
Ordinary
Sale
500
4507
Ordinary
Sale
1,100
4503
Ordinary
Sale
900
4513
Ordinary
Sale
400
4511
Ordinary
Sale
400
4507
Ordinary
Sale
200
4507
Ordinary
Sale
1,100
4506
Ordinary
Sale
700
4510
Ordinary
Sale
1,100
4518
Ordinary
Sale
1,300
4514
Ordinary
Sale
100
4502
Ordinary
Sale
400
4513
Ordinary
Sale
1,300
4484
Ordinary
Sale
1,100
4495
Ordinary
Sale
400
4509
Ordinary
Sale
700
4511
Ordinary
Sale
300
4522
Ordinary
Sale
100
4511
Ordinary
Sale
100
4526
Ordinary
Sale
100
4543
Class of relevant security
Purchase/sale
Number of securities
Price per unit
USD
ADS
Sale
25,170
19.803433
ADS
Sale
138,435
19.803433
Total Purchases
277,005
Total Sales
327,405
(b) Cash-settled derivative transactions
Class of relevant security
Product description
e.g. CFD
Nature of dealing
e.g. opening/closing a long/short position, increasing/reducing a long/short position
Number of reference securities
Price per unit JPY
Ordinary
Certificate
Closing a short position
2,061
4514.318731
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of relevant security
Product description e.g. call option
Writing, purchasing, selling, varying etc.
Number of securities to which option relates
Exercise price per unit
Type
e.g. American, European etc.
Expiry date
Option money paid/ received per unit JPY
(ii) Exercise
Class of relevant security
Product description
e.g. call option
Exercising/ exercised against
Number of securities
Exercise price per unit JPY
(d) Other dealings (including subscribing for new securities)
Class of relevant security
Nature of dealing
e.g. subscription, conversion
Details
Price per unit (if applicable) JPY
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached?
YES
Date of disclosure:
14/11/2018
Contact name:
Olivier Vero
Telephone number:
+44 20 7676 6969
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure:
SOCIETE GENERALE SA
Name of offeror/offeree in relation to whose relevant securities the disclosure relates:
Takeda Pharmaceutical CO LTD
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of relevant security
Product description e.g. call option
Written or purchased
Number of securities to which option or derivative relates
Exercise price per unit
Type
Expiry date
JPY
e.g. American, European etc.
Ordinary
OTC put-option
Sale
15,700
4707
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,000
5075.10
European options
14/12/2018
Ordinary
OTC put-option
Sale
29,600
5073.65
European options
14/12/2018
Ordinary
OTC put-option
Sale
15,500
4491.40
European options
14/12/2018
Ordinary
OTC put-option
Sale
30,700
4533.90
European options
14/12/2018
Ordinary
Listed call-option
Sale
125,000
5500
European options
13/06/2019
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:
It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be stated.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.ENDRETGGGQUGUPRUBC
Recent news on Takeda Pharmaceutical Co
See all newsREG - Malin Corp PLC - Malin Announces 2021 Full Year Results
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Confirmation of post-offer intention statements
AnnouncementREG - Morgan Stanley&CoLLC Takeda Pharma.Co.Ltd - Form 8.5 (EPT/RI) - Replacement of Takeda
AnnouncementREG - Takeda Pharma.Co.Ltd Shire plc - Statement re Applicable Exchange Rate
AnnouncementREG - Morgan Stanley Takeda Pharma.Co.Ltd - Form 8.5 (EPT/NON-RI) - Replacement of Takeda
Announcement